Nearly 20.5 million Americans suffer from a substance use disorder (SUD), yet only 1 in 10 people with a substance use disorder (SUD) receive treatment. This treatment gap leaves millions without the proper treatment, expanding the addiction medicine workforce is vital. During this webinar, we will discuss how physicians can become board-certified in Addiction Medicine under the new medical subspecialty. 

The 60-minute webinar will provide insights into current addiction treatment gap and how physicians can close this gap by becoming board-certified in addiction medicine certified through the upcoming American Board of Preventive Medicine addiction medicine exam.

Kelly Clark, MD, MBA, DFASAM, 

American Society of Addiction Medicine (ASAM)

Wilson Compton, MD, MPE
Deputy Director
National Institute on Drug Abuse (NIDA)

Michael Weaver, MD, FASAM
Chair, Exam Committee 
American Board of Preventive Medicine (ABPM)

Mitra Ahadpour, MD, DABAM,
Director, Division of Pharmacologic Therapies
Substance Abuse and Mental Health Service Administration (SAMHSA)

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Demonstrate the importance of the need for an expanded workforce.
  • Describe the different hurdles patients faces when seeking treatment for addiction treatment.
  • Identify different demographics that are uniquely affected by the treatment gap.
  • Diagram the different learning methods physicians can take to educate themselves in addiction medicine.
  • Construct an outline of the different pathways physicians can take to become eligible to sit for the addiction medicine exam.
  • Identify certain criteria physicians have to uphold in order to become an addiction specialist.. 

Close The Gap: Pathways to the Addiction Medicine Exam Webinar

Please log-in or register to access this webinar.

Target Audience

  • Addiction medicine specialists
  • Opioid treatment program providers
  • DATA-waived provider
  • Public health management services providers